[Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia]

Nihon Naibunpi Gakkai Zasshi. 1986 Jun 20;62(6):683-96. doi: 10.1507/endocrine1927.62.6_683.
[Article in Japanese]

Abstract

An enzyme immunoassay for measuring 17 alpha-hydroxyprogesterone (17-OHP) in dried blood collected on filter paper has been developed. The method is easy and rapid and has specificity, accuracy and precision. 17-OHP values of neonates with congenital adrenal hyperplasia (CAH, 40 ng/ml) were extremely high compared with normal neonates (1.1 +/- 0.7 ng/ml). There was a negative correlation between the 17-OHP value and birth weight. The method has been applied to neonatal screening for CAH due to 21-hydroxylase deficiency. During 38 months, 67,392 neonates were screened. The recall rate and the medical evaluation rate were 1.16% and 0.09%, respectively. A third of recalled neonates were low birth weight infants. 5 neonates were proven to have CAH, and its incidence was 1:13,478. The present study demonstrates the feasibility of a neonatal screening for CAH and indicates that the frequency of CAH may be greater than previously reported by case assessment method in Japan.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 17-alpha-Hydroxyprogesterone
  • Adrenal Hyperplasia, Congenital* / epidemiology*
  • Humans
  • Hydroxyprogesterones / blood*
  • Immunoenzyme Techniques*
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Japan
  • Mass Screening / methods*
  • Reference Values
  • Steroid Hydroxylases / deficiency*

Substances

  • Hydroxyprogesterones
  • 17-alpha-Hydroxyprogesterone
  • Steroid Hydroxylases